Exercise and fasting trigger longevity genes to repair cellular damage and slow aging.
"when you go for a run or you're fasting, the reason that those are beneficial, actually, is because they trigger those longevity genes to repair your body and make sure that you don't get as old as you would otherwise." (said at 0:01:43)
Exercise and fasting (or caloric restriction) are well-established to induce mild energetic stress that activates evolutionarily conserved nutrient-sensing pathways and 'longevity' regulators—principally AMP-activated protein kinase (AMPK) and sirtuins (SIRT1–7)—while inhibiting mTOR. Activation of these pathways upregulates cellular maintenance, autophagy, mitochondrial biogenesis, and DNA repair mechanisms, and has been associated with improvements in epigenetic aging biomarkers and metabolic health in humans. However, while lifespan extension through these mechanisms is consistently demonstrated in model organisms, definitive evidence that these pathways slow chronological aging or extend maximum human lifespan remains an area of ongoing translational research.
- context: Dietary and Pharmacological Modulation of Aging-Related Metabolic Pathways: Molecular Insi… (International journal of molecular sciences 2025) · cited 14x in the literature
"Across modalities, CR and IF consistently activate AMP-activated protein kinase and sirtuins, inhibit mTOR (mechanistic target of rapamycin) signaling, and enhance autophagy, aligning with improvements in insulin sensitivity, lipid profile, low-grade inflammation, and selected epigenetic aging measures in humans." (abstract, results, passage verified)
pubmedfull study (doi) - context: From Elixirs to Geroscience: A Historical and Molecular Perspective on Anti-Aging Medicine… (Molecules (Basel, Switzerland) 2025) · cited 5x in the literature
"Central roles are played by nutrient-sensing networks such as mTOR, AMPK, and sirtuins, together with mitochondrial regulation, proteostasis, and cellular senescence. Interventions, including caloric restriction, fasting-mimicking diets, rapalogues, sirtuin activators, metformin, NAD + boosters, senolytics, and antioxidant combinations such as GlyNAC, show consistent benefits across multiple model organisms, with early human trials reporting improvements in immune function, mitochondrial activity, and biomarkers of aging." (abstract, results, passage verified)
pubmedfull study (doi)
Resveratrol acts as an allosteric activator that accelerates sirtuin enzyme activity.
"And then the resveratrol that we worked on years ago works on the same enzymes, but it's the accelerator pedal. So the NAD is making it work, but resveratrol will come along and make it work even faster." (said at 0:15:52)
Structural and biochemical studies demonstrate that resveratrol can bind to an N-terminal domain on SIRT1 and act as an allosteric activator to increase its deacetylase activity. However, this activation is highly substrate-dependent: while resveratrol increases SIRT1 activity in the presence of synthetic fluorophore-tagged peptides or substrates containing specific hydrophobic motifs, it does not directly accelerate SIRT1 activity across all native, un-tagged substrates (such as standard native p53 or PGC-1alpha peptides). Because support is limited to in vitro biochemical and structural assays and depends on substrate structure, the claim requires qualification.
- contradicts: Resveratrol is not a direct activator of SIRT1 enzyme activity. (Chemical biology & drug design 2009) · cited 424x in the literature
"resveratrol does not activate SIRT1 in vitro in the presence of either a p53-derived peptide substrate or acetylated PGC-1alpha isolated from cells" (abstract, results, passage verified)
pubmedfull study (doi) - supports: Evidence for a common mechanism of SIRT1 regulation by allosteric activators. (Science (New York, N.Y.) 2013) · cited 26x in the literature
"Thus, SIRT1 can be directly activated through an allosteric mechanism common to chemically diverse STACs." (abstract, conclusions, passage verified)
pubmedfull study (doi) - partial: Structural basis for allosteric, substrate-dependent stimulation of SIRT1 activity by resv… (Genes & development 2015) · cited 256x in the literature
"Structural basis for allosteric, substrate-dependent stimulation of SIRT1 activity by resveratrol." (abstract, title, passage verified)
pubmedfull study (doi)
Unstabilized NR and NMN degrade into nicotinamide at room temperature, and high doses of nicotinamide inhibit sirtuins and PARP and impair DNA repair.
"If it's just on the shelf and it's not in a stabilized form, then it will degrade into nicotinamide, which is something you don't want to take high doses of, because we showed in my lab many years ago that nicotinamide will inhibit the sirtuins and PARP as well, and interfere with DNA repair." (said at 0:57:42)
The claim is partially accurate but requires qualification. Research from Sinclair's lab established that nicotinamide is an endogenous, noncompetitive inhibitor of sirtuins such as yeast Sir2 and human SIRT1 in vitro (IC50 < 50 µM). Nicotinamide is also a well-characterized product inhibitor of PARP enzymes. However, while NMN and NR can hydrolyze to nicotinamide over time, standard commercial formulations stored under recommended ambient conditions remain relatively stable, and human clinical trials using oral NMN or NR supplementation have not demonstrated significant toxicity or functional suppression of DNA repair.